Fund shareholders of Anavex Life Sciences Corp
ISIN US0327973006 · United States · LEI 549300K1I5L8COCQ8W36
- Fund shareholders
- 111
- Of which ETFs
- 22 89 other funds
- Value held
- 42.8M $
- Share of capital
- 17.1 % of 92.7M shares on Aug 28, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 496 | 1.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 379 | 981.6 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 247 | 639.7 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 228 | 590.5 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 136 | 352.2 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 105 | 272 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 82 | 248.5 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 78 | 214.5 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 40 | 110 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 26 | 67.3 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 25 | 75.8 $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Defiance Autism Impact ETF ETF Series Solutions | 2.53 % | as of Jun 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.27 % | as of Jul 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 0.25 % | as of Jul 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.22 % | as of Jun 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.18 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.05 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.02 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 0.01 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 111 | -3 | 15,874,217 | -0.7 % |
| 2026Q2 | 114 | -2 | 15,982,131 | +4.3 % |
| 2026Q1 | 116 | -6 | 15,320,774 | +11.4 % |
| 2025Q4 | 122 | 0 | 13,757,116 | -7.7 % |
| 2025Q3 | 122 | -6 | 14,902,621 | +3.0 % |
| 2025Q2 | 128 | +10 | 14,461,557 | +11.3 % |
| 2025Q1 | 118 | -1 | 12,992,052 | -6.0 % |
| 2024Q4 | 119 | +9 | 13,825,560 | -0.6 % |
| 2024Q3 | 110 | -9 | 13,905,757 | -20.3 % |
| 2024Q2 | 119 | 0 | 17,457,450 | +29.4 % |
| 2024Q1 | 119 | +6 | 13,494,317 | +5.2 % |
| 2023Q4 | 113 | 12,821,856 |
Institutional managers
180 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 7,609,618 | 23.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,512,028 | 13.9M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,247,888 | 10M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,188,275 | 6.7M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 995,663 | 3.1M $ | as of Mar 31, 2026 |
| Summit Financial, LLC | 940,455 | 2.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 863,150 | 2.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 804,435 | 2.5M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 756,792 | 2.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 756,558 | 2.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 725,187 | 2.2M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 725,003 | 2.2M $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 657,877 | 2K $ | as of Mar 31, 2026 |
| UBS Group AG | 569,956 | 1.7M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 559,435 | 1.7M $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 538,277 | 1.7M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 532,252 | 1.6M $ | as of Mar 31, 2026 |
| Private Advisor Group, LLC | 499,700 | 1.5M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 419,497 | 1.3M $ | as of Mar 31, 2026 |
| LPL Financial LLC | 418,640 | 1.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 357,747 | 1.1M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 276,800 | 849.8K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 258,071 | 792.3K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 247,849 | 760.9K $ | as of Mar 31, 2026 |
| STIFEL FINANCIAL CORP | 236,804 | 727K $ | as of Mar 31, 2026 |
Declared shareholders of Anavex Life Sciences Corp
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.03 % | 4,663,459 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Anavex Life Sciences Corp". https://titelia.com/en/stocks/anavex-life-sciences-corp-US0327973006